Walgreens Boots Alliance Inc. is weighing a sale of its pharmacy automation business, which could fetch up to $2 billion, according to people familiar with the matter. The company, which is working with an advisers, is preparing to start a sales process in the next month or so for iA, said the people, who asked to not be identified because the matter is private.
The four-decades long effort to create an HIV vaccine suffered a blow last week with news that Janssen Pharmaceuticals was discontinuing the only current late-stage clinical trial of a vaccine. Results showed it to be ineffective.
Many doctors worry that the drugs' current popularity, fueled in part by social media, has resulted in people taking them without sufficient medical supervision.
The addiction crisis is increasingly eroding health systems' finances, with the treatment of opioid use disorder costing hospitals more than $95 billion a year, new data from Premier Inc. shows.
A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.